ISPOR Europe 2022 Home
  • Program
    • Program
      • Session
      • Paper
    • Learning Formats
    • Plenary Sessions
    • Spotlight Sessions
    • Posters
    • Educational Symposia & HEOR Theater
    • Program Committee
    • Speaker & Poster Presenter Resources
    • Student Program
large-circle

ISPOR Europe 2022

6 - 9 November

  • Home
  • Events
  • Past Conferences
  • Program
  • Program
  • Session

  • Avalglucosidase Alfa (AVA) Improves Symptoms and Functioning in Late-Onset Pompe Disease (LOPD) Patients vs Alglucosidase Alfa (ALG): Post-Hoc Analyses of Patient-Reported Outcomes (PROs) From COMET Trial

    Nov 7, 2022, 15:00 PM
  • «
  • 1731
  • 1732
  • 1733
  • 1734
  • 1735
  • 1736 (current)
  • 1737
  • 1738
  • 1739
  • 1740
  • »
Quick Links
  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal
  • Antitrust Compliance
  • Code of Ethics
  • Cookie Policy
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy
  • Terms and Conditions

Subscribe

Join ISPOR

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group